Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
Where
Shanghai
Age
18 years to 75 years
People
54
Run by
Shanghai Chest Hospital
See details and how to joinNCT06127303
Phase 2Not yet taking people in China
Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
Where
Shanghai
Age
18 years and over
People
30
Run by
Fudan University
See details and how to joinNCT07156604
Phase 1Taking people
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
15
Run by
Guangzhou FineImmune Biotechnology Co., LTD.
See details and how to joinNCT06942143
Phase 2Not yet taking people in China
Nebulized Inhalation of Recombinant Human p53 Adenovirus Injection for Treatment of Multiple Ground-Glass Lung Nodules: A Single-Arm Clinical Study
Where
Guangzhou
Age
18 years and over
People
38
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07150416
No phaseTaking people
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
Where
Beijing
Age
18 years to 85 years
People
20,000
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06483698
No phaseTaking people
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
Where
Shanghai
Age
18 years to 75 years
People
545
Run by
Fudan University
See details and how to joinNCT04527419
Phase 1Taking people
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors
Where
Shanghai
Age
18 years and over
People
31
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07056556
No phaseNot yet taking people in China
Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules
Where
Beijing, Nanjing, Ningbo, Shanghai, Zhengzhou
Age
18 years and over
People
465
Run by
Shanghai Chest Hospital
See details and how to joinNCT07135297
Phase 1Taking people
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Where
Zhengzhou
Age
18 years to 75 years
People
21
Run by
GONGCHU Biotechnology Co., Ltd
See details and how to joinNCT06508307
No phaseTaking people
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
Where
Shanghai
Age
18 years to 75 years
People
39
Run by
Fudan University
See details and how to joinNCT06258642
No phaseTaking people
Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes
Where
Wuhan
Age
18 years and over
People
100
Run by
Qian Chu
See details and how to joinNCT07131670
Phase 2Not yet taking people in China
Iparomlimab and Tuvonralimab Combined With 2 or 4 Cycles of Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
Where
Guangzhou, Xi’an
Age
18 years and over
People
66
Run by
Sun Yat-sen University
See details and how to joinNCT07129161
No phaseEnrolling by invitation
The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracoscopic Surgery
Where
Kunming
Age
18 years to 65 years
People
120
Run by
First Affiliated Hospital of Kunming Medical University
See details and how to joinNCT07125573
No phaseTaking people
Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm
Where
Shanghai
Age
18 years to 80 years
People
684
Run by
Fudan University
See details and how to joinNCT06634979
Phase 1Taking people
The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)
Where
Beijing
Age
18 years and over
People
18
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06861543
Phase 1Taking people
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
Where
Zhengzhou
Age
18 years and over
People
80
Run by
The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06896422
Phase 2Taking people
Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy
Where
Guangzhou
Age
18 years to 75 years
People
211
Run by
Wen-zhao ZHONG
See details and how to joinNCT07039656
Phase 2Taking people
Perioperative Immunotherapy for Resectable Limited-Stage SCLC
Where
Shanghai
Age
18 years to 75 years
People
37
Run by
Fudan University
See details and how to joinNCT07109401
Phase 2Not yet taking people in China
A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer
Where
Guangzhou
Age
18 years to 75 years
People
56
Run by
Sun Yat-sen University
See details and how to joinNCT07103408
Phase 2Not yet taking people in China
A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy
Where
Nanjing, Shanghai
Age
18 years and over
People
149
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07101627
Phase 2/3Taking people
A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer
Where
Hangzhou, Tianjin
Age
18 years to 75 years
People
1,080
Run by
Hansoh BioMedical R&D Company
See details and how to joinNCT06417008
Phase 2Taking people
Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC
Where
Beijing
Age
18 years and over
People
90
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06897046
Phase 2Not yet taking people in China
Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033
Where
Shanghai
Age
18 years and over
People
40
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07097948
No phaseTaking people
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
Where
Beijing
Age
50 years to 90 years
People
1,988
Run by
Peking University First Hospital
See details and how to joinNCT04209218
Phase 1Taking people
SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection
Where
Chengdu
Age
18 years to 70 years
People
22
Run by
Cytocraft Biopharmaceutical Co., Ltd.
See details and how to joinNCT07096882